The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$500

2018 promises to be a year of continued innovation in the biopharmaceutical industry across therapy areas. In this report, GlobalData’s analysts highlight a selection of highly anticipated events, including regulatory approvals, product launches, and clinical trial milestones throughout the year.

Scope

GlobalData’s The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area provides an insight-rich overview of the key events and trends that our analysts expect to occur during 2018. This forward-looking view of the industry identifies key events that will occur across the major therapeutic areas – oncology, immunology, neurology, cardiovascular diseases, metabolic disorders, infectious diseases, and ophthalmology – and provides analyst insight on the potential ramifications of each event.

For each therapeutic area, the report includes a timeline of events by quarter and analysis of each event. Selected events and insights include:

• Within the oncology space, GlobalData anticipates that Keytruda will receive FDA approval for adjuvant treatment of melanoma during Q4 2018. In December 2017, the FDA approved Bristol-Myers Squibb’s PD-1 inhibitor Opdivo (nivolumab) as an adjuvant treatment for patients with completely resected melanoma with lymph node involvement or metastatic disease. Although Keytruda’s head-to-head competitor Opdivo has a head start in this lucrative setting, the adjuvant indication could help close the gap for Keytruda. GlobalData expects Keytruda to be a bonafide rival to Opdivo in the adjuvant melanoma setting, with the two drugs splitting the market equally by 2026.

• Within the immunology space, GlobalData anticipates 2018 BLA submissions of DBV Technologies’ Viaskin Peanut and Aimmune’s AR-101 for peanut allergy (PNA). Armed with positive clinical results from recent pivotal trials, both companies are slated to submit BLAs in 2018 for their respective peanut allergy therapies. Currently available drugs on the market treat the inflammatory symptoms that occur following the accidental exposure to peanut and not the underlying allergy itself. Therefore, these novel immunotherapies will be the first to launch for treating the disease and will revolutionize the field.

• In the vaccines market, GlobalData anticipates the initial data from Takeda’s pivotal Phase III study evaluating the efficacy and safety of its dengue vaccine candidate, TAK-003, to be announced in H2 2018. The results of this study, which has enrolled over 20,000 children and adolescents across eight dengue-endemic countries, could propel Takeda ahead of rival Sanofi in the dengue vaccine space. Takeda is also investigating the immunogenicity and safety of TAK-003 in non-endemic areas in an ongoing Phase III study (NCT03341637), with initial results also expected in 2018.

Reasons to Buy

Identify the most impactful anticipated regulatory approvals and drug launches in the industry in 2018 by therapeutic area.

Gain insight into the potential ramifications of key product approvals, including the effect of their market entrance on the competitive landscape.

Understand which clinical trial milestones and data readouts in 2018 are likely to make the greatest impact on treatment paradigms across multiple indications, including both large, well-established disease markets and smaller markets for underserved diseases.

Companies with anticipated major events in 2018 – from clinical trial milestones to product approvals – in each of the following therapeutic areas are mentioned: oncology
immunology
neurology
cardiovascular diseases
metabolic disorders
infectious diseases
and ophthalmology.

Table of Contents

Introduction

Classification of Events

Major Events Year-to-Date: January

Major Events Year-to-Date: February

Oncology

Key Anticipated Events in Oncology and Hematology in 2018

Key Events and Trends to Watch for in Hematological Cancers

Key Events and Trends to Watch for in Gastrointestinal Cancers

Key Events and Trends to Watch for in Genitourinary Cancers

Key Events and Trends to Watch for in Skin Cancers

Key Events and Trends to Watch for in Lung and Brain Cancers

Immunology

Key Anticipated Events in Immunology in 2018

Key Events and Trends to Watch for in Autoimmune Diseases

Key Events and Trends to Watch for in Dermatology

Key Events and Trends to Watch for in Respiratory and Gastrointestinal Diseases

Key Events and Trends to Watch for in Rare and Other Immunological Diseases

Neurology

Top Players in Neurology in 2017

Key Events and Trends to Watch for in Epilepsy

Key Events and Trends to Watch for in Multiple Sclerosis

Key Events and Trends to Watch for in Migraine

Key Events and Trends to Watch for in Parkinson’s Disease and Alzheimer’s Disease

Key Events and Trends to Watch for in Diabetic Neuropathic Pain, Acute Ischemic Stroke, and Amyotrophic Lateral Sclerosis

Cardiovascular and Metabolic Disorders

Key Anticipated Events in CVMD in 2018

Key Events and Trends to Watch for in Osteoporosis and Endometriosis

Key Events and Trends to Watch for in Selected Metabolic Disorders

Key Events and Trends to Watch for in Diabetes

Key Events and Trends to Watch for in Cardiovascular Diseases

Infectious Diseases

Key Anticipated Events in Infectious Diseases in 2018

Key Events and Trends to Watch for in HIV and Hepatitis C

Key Events and Trends to Watch for in Vaccines

Key Events and Trends to Watch for in Antimicrobials

Ophthalmology

Key Anticipated Events in Ophthalmology in 2018

Key Events and Trends to Watch for in Glaucoma

Key Events and Trends to Watch for in Uveitis

Key Events and Trends to Watch for in Age-Related Macular Degeneration

Key Events and Trends to Watch for in Dry Eye Syndrome and Macular Edema

Appendix

Contributors

About GlobalData

Contact Us

Disclaimer

Table

Table 1: Classification of Events

Table 2: Key Anticipated Events in Oncology in 2018

Table 3: Key Events and Trends to Watch for in Hematological Cancers

Table 4: Key Events and Trends to Watch for in Gastrointestinal Cancers

Table 5: Key Events and Trends to Watch for in Genitourinary Cancers

Table 6: Key Events and Trends to Watch for in Skin Cancers

Table 7: Key Events and Trends to Watch for in Lung and Brain Cancers

Table 8:Key Anticipated Events in Immunology in 2018

Table 9:Key Events and Trends to Watch for in Autoimmune Diseases

Table 10: Key Events and Trends to Watch for in Dermatology

Table 11: Key Events and Trends to Watch for in Respiratory and Gastrointestinal Diseases

Table 12: Key Events and Trends to Watch for in Rare and Other Immunological Diseases

Table 13: Key Anticipated Events in Neurology in 2018

Table 14: Key Events and Trends to Watch for in Epilepsy

Table 15: Key Events and Trends to Watch for in Multiple Sclerosis

Table 16: Key Events and Trends to Watch for in Migraine

Table 17: Key Events and Trends to Watch for in Parkinson’s Disease and Alzheimer’s Disease

Table 18: Key Events and Trends to Watch for in Diabetic Neuropathic Pain, Acute Ischemic Stroke, and Amyotrophic Lateral Sclerosis

Table 19: Key Anticipated Events in CVMD in 2018

Table 20: Key Events and Trends to Watch for in Osteoporosis and Endometriosis

Table 21: Key Events and Trends to Watch for in Selected Metabolic Disorders

Table 22: Key Events and Trends to Watch for in Diabetes

Table 23: Key Events and Trends to Watch for in Cardiovascular Diseases

Table 24: Key Anticipated Events in Infectious Diseases in 2018

Table 25: Key Events and Trends to Watch for in HIV and Hepatitis C

Table 26: Key Events and Trends to Watch for in Vaccines

Table 27: Key Events and Trends to Watch for in Antimicrobials

Table 28: Key Anticipated Events in Ophthalmology in 2018

Table 29: Key Events and Trends to Watch for in Glaucoma

Table 30: Key Events and Trends to Watch for in Uveitis

Table 31: Key Events and Trends to Watch for in Age-Related Macular Degeneration

Table 32: Key Events and Trends to Watch for in Dry Eye Syndrome and Macular Edema

Frequently asked questions

The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area standard reports
Currency USD
$500

Can be used by individual purchaser only

$1,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area in real time.

  • Access a live The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.